Literature DB >> 2909748

N6-bicycloalkyladenosines with unusually high potency and selectivity for the adenosine A1 receptor.

B K Trivedi1, A J Bridges, W C Patt, S R Priebe, R F Bruns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2909748     DOI： 10.1021/jm00121a002

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  11 in total

1.  Evidence for the presence of A1 and A2 adenosine receptors in the ventral aorta of the dogfish shark, Squalus acanthias.

Authors:  D H Evans
Journal:  J Comp Physiol B       Date:  1992       Impact factor: 2.200

2.  Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A3 adenosine receptor antagonists.

Authors:  Jinha Yu; Philip Mannes; Young-Hwan Jung; Antonella Ciancetta; Amelia Bitant; David I Lieberman; Sami Khaznadar; John A Auchampach; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Medchemcomm       Date:  2018-10-18       Impact factor: 3.597

3.  Hypothermia in mouse is caused by adenosine A1 and A3 receptor agonists and AMP via three distinct mechanisms.

Authors:  Jesse Lea Carlin; Shalini Jain; Elizabeth Gizewski; Tina C Wan; Dilip K Tosh; Cuiying Xiao; John A Auchampach; Kenneth A Jacobson; Oksana Gavrilova; Marc L Reitman
Journal:  Neuropharmacology       Date:  2016-11-30       Impact factor: 5.250

4.  Inhibition by adenosine A(2A) receptors of NMDA but not AMPA currents in rat neostriatal neurons.

Authors:  K Wirkner; H Assmann; L Köles; Z Gerevich; H Franke; W Nörenberg; R Boehm; P Illes
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

5.  Evidence for the presence of A(1) adenosine receptors in the aorta of spontaneously hypertensive rats.

Authors:  M Fahim; S J Mustafa
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

6.  2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA)--a high affinity agonist radioligand for A1 adenosine receptors.

Authors:  K N Klotz; M J Lohse; U Schwabe; G Cristalli; S Vittori; M Grifantini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

7.  Design and in Vivo Characterization of A1 Adenosine Receptor Agonists in the Native Ribose and Conformationally Constrained (N)-Methanocarba Series.

Authors:  Dilip K Tosh; Harsha Rao; Amelia Bitant; Veronica Salmaso; Philip Mannes; David I Lieberman; Kelli L Vaughan; Julie A Mattison; Amy C Rothwell; John A Auchampach; Antonella Ciancetta; Naili Liu; Zhenzhong Cui; Zhan-Guo Gao; Marc L Reitman; Oksana Gavrilova; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2019-01-03       Impact factor: 7.446

Review 8.  Novel therapeutics acting via purine receptors.

Authors:  K A Jacobson; B K Trivedi; P C Churchill; M Williams
Journal:  Biochem Pharmacol       Date:  1991-05-15       Impact factor: 5.858

Review 9.  Adenosine A1 and A2 receptors: structure--function relationships.

Authors:  P J van Galen; G L Stiles; G Michaels; K A Jacobson
Journal:  Med Res Rev       Date:  1992-09       Impact factor: 12.944

Review 10.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

Authors:  B B Fredholm; A P IJzerman; K A Jacobson; K N Klotz; J Linden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 18.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.